Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Pancreatic Neoplasms 1Fanconi Anemia, Complementation Group D1 1Breast Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 2Whole-Body Irradiation 2Methotrexate 2Cyclosporine 2Cyclophosphamide 2Busulfan 2siltuximab 1pegylated granulocyte colony-stimulating factor 1magrolimab 1hetrombopag 1fludarabine 1ferric gluconate 1decitabine and cedazuridine drug combination 1ceftolozane, tazobactam drug combination 1avatrombopag 1Transplantation 1Tacrolimus 1Radiotherapy 1Pluvicto 1Pentostatin 1Mycophenolic Acid 1Micafungin 1Meropenem 1Iron-Dextran Complex 1Iron 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Holistic Health 1Genotype 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Genotype × Classical hematology × Clear all
NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Memorial Sloan Kettering Cancer Center

Withdrawn
BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡